Drawing for OCUBIO

USPTO serial 98468103

OCUBIO

Reviewed by CopyMark Law Group

Reg. 7996434Status 700Registered
Filing date
Status date
Registration date
Oct 21, 2025
Examiner
SCHRADER, BRITTANY A
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OCUBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Katherine Koenig

Katherine Koenig Koenig IP Works, PLLC2208 Mariner Dr.Fort Lauderdale, FL 33316United States

Goods and services

ClassDescriptionStatusFirst use
005Eye drops; ocular pharmaceuticals; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; pharmaceutical preparations for ocular or intraocular surgeryACTIVEMar 3, 2025
044Pharmaceutical compounding services [ ; medical diagnostic services; blood analysis services for diagnostic purposes provided by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; blood serum analysis services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing services of blood serums; medical testing services of tear fluid ]ACTIVEMar 3, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Sep 18, 2026COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Sep 7, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 23, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Jun 19, 2026ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jun 3, 2026A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Jun 3, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 21, 2026ES7RTEAS SECTION 7 REQUEST RECEIVED—
Mar 31, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Mar 12, 2026A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Mar 9, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 9, 2025ES7RTEAS SECTION 7 REQUEST RECEIVED—
Oct 21, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 21, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 1, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 1, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 1, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 1, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 3, 2025IUAFUSE AMENDMENT FILED—
May 3, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 31, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 19, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 19, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 7, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 4, 2024DOCKASSIGNED TO EXAMINER—
Aug 26, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 26, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance